Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February
The SARS-CoV-2 B.1.1.7 variant of concern (VOC) is increasing in prevalence across Europe. Accurate estimation of disease severity associated with this VOC is critical for pandemic planning. We found increased risk of death for VOC compared with non-VOC cases in England (hazard ratio: 1.67; 95% confidence interval: 1.34-2.09; p < 0.0001). Absolute risk of death by 28 days increased with age and comorbidities. This VOC has potential to spread faster with higher mortality than the pandemic to date.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin - 26(2021), 11 vom: 18. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Grint, Daniel J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
CFR |
|---|
| Anmerkungen: |
Date Completed 24.03.2021 Date Revised 06.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2807/1560-7917.ES.2021.26.11.2100256 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM322957427 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM322957427 | ||
| 003 | DE-627 | ||
| 005 | 20240306232014.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2807/1560-7917.ES.2021.26.11.2100256 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1318.xml |
| 035 | |a (DE-627)NLM322957427 | ||
| 035 | |a (NLM)33739254 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Grint, Daniel J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.03.2021 | ||
| 500 | |a Date Revised 06.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The SARS-CoV-2 B.1.1.7 variant of concern (VOC) is increasing in prevalence across Europe. Accurate estimation of disease severity associated with this VOC is critical for pandemic planning. We found increased risk of death for VOC compared with non-VOC cases in England (hazard ratio: 1.67; 95% confidence interval: 1.34-2.09; p < 0.0001). Absolute risk of death by 28 days increased with age and comorbidities. This VOC has potential to spread faster with higher mortality than the pandemic to date | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a CFR | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Case fatality risk | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Mortality | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Variant of concern | |
| 700 | 1 | |a Wing, Kevin |e verfasserin |4 aut | |
| 700 | 1 | |a Williamson, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a McDonald, Helen I |e verfasserin |4 aut | |
| 700 | 1 | |a Bhaskaran, Krishnan |e verfasserin |4 aut | |
| 700 | 1 | |a Evans, David |e verfasserin |4 aut | |
| 700 | 1 | |a Evans, Stephen Jw |e verfasserin |4 aut | |
| 700 | 1 | |a Walker, Alex J |e verfasserin |4 aut | |
| 700 | 1 | |a Hickman, George |e verfasserin |4 aut | |
| 700 | 1 | |a Nightingale, Emily |e verfasserin |4 aut | |
| 700 | 1 | |a Schultze, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Rentsch, Christopher T |e verfasserin |4 aut | |
| 700 | 1 | |a Bates, Chris |e verfasserin |4 aut | |
| 700 | 1 | |a Cockburn, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Curtis, Helen J |e verfasserin |4 aut | |
| 700 | 1 | |a Morton, Caroline E |e verfasserin |4 aut | |
| 700 | 1 | |a Bacon, Sebastian |e verfasserin |4 aut | |
| 700 | 1 | |a Davy, Simon |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Angel Ys |e verfasserin |4 aut | |
| 700 | 1 | |a Mehrkar, Amir |e verfasserin |4 aut | |
| 700 | 1 | |a Tomlinson, Laurie |e verfasserin |4 aut | |
| 700 | 1 | |a Douglas, Ian J |e verfasserin |4 aut | |
| 700 | 1 | |a Mathur, Rohini |e verfasserin |4 aut | |
| 700 | 1 | |a Blomquist, Paula |e verfasserin |4 aut | |
| 700 | 1 | |a MacKenna, Brian |e verfasserin |4 aut | |
| 700 | 1 | |a Ingelsby, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Croker, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Parry, John |e verfasserin |4 aut | |
| 700 | 1 | |a Hester, Frank |e verfasserin |4 aut | |
| 700 | 1 | |a Harper, Sam |e verfasserin |4 aut | |
| 700 | 1 | |a DeVito, Nicholas J |e verfasserin |4 aut | |
| 700 | 1 | |a Hulme, Will |e verfasserin |4 aut | |
| 700 | 1 | |a Tazare, John |e verfasserin |4 aut | |
| 700 | 1 | |a Goldacre, Ben |e verfasserin |4 aut | |
| 700 | 1 | |a Smeeth, Liam |e verfasserin |4 aut | |
| 700 | 1 | |a Eggo, Rosalind M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin |d 1995 |g 26(2021), 11 vom: 18. März |w (DE-627)NLM115683283 |x 1560-7917 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2021 |g number:11 |g day:18 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2807/1560-7917.ES.2021.26.11.2100256 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2021 |e 11 |b 18 |c 03 | ||